Georges Gemayel is an American businessperson who has been at the helm of 10 different companies. He is Non-Executive Chairman of Enterome SA, Chairman for Orphazyme A, Chairman for Dynacure SAS and Chairman of OxThera AB. Dr. Gemayel is also on the board of Momenta Pharmaceuticals, Inc., Supernus Pharmaceuticals, Inc., International Institute of New England and Gemayel Family Foundation and Partner at Gemayel Investment LLC.
In the past Dr. Gemayel held the position of Executive Chairman of Vascular Magnetics, Inc., Chairman, President & Chief Executive Officer at Altus Pharmaceuticals, Inc., Chairman for Syndexa Pharmaceuticals Corp., Executive Chairman of Syndex Corp., Vice President-Specialty Care at Roche Corp., Executive Chairman for FoldRx Pharmaceuticals, Inc., Chairman for EpiTherapeutics ApS, Vice President-National Specialty Care at Hoffmann-La Roche, Inc., General Manager of Hoffmann-La Roche Portugal, General Manager of Roche Farmaceutica Quimica Ltda and Executive Vice President-Therapeutics at Genzyme Corp.
Dr. Gemayel received a doctorate from St. Joseph University and a doctorate and a graduate degree from Université Paris-Sud 11.
|08/05/2020||10,000||Disposition at $33 per share.||330,000|
|08/05/2020||10,000||Derivative/Non-derivative trans. at $14.84 per share.||148,400|
|07/29/2020||10,000||Disposition at $30 per share.||300,000|
|07/29/2020||10,000||Derivative/Non-derivative trans. at $14.84 per share.||148,400|
|06/20/2019||4,356||Derivative/Non-derivative trans. at $0 per share.||0|
|06/20/2018||5,734||Derivative/Non-derivative trans. at $0 per share.||0|